导管原位癌患者的术前MRI:MRI是否有助于识别额外病变
回顾性分析2007至2016年963例乳腺X线钙化且空心针活检为导管原位癌的女性,其中236例(24.5%)术前行MRI。MRI组在24例(11.2%,24/215)患者中检出额外癌灶,26个癌灶中13个(50.0%)为导管原位癌、13个(50.0%)为浸润癌,作者认为可考虑在此特定人群的术前评估中使用MRI。
要点
- 活检为导管原位癌的患者中,24.5%(236/963)术前行MRI检查。
- MRI在11.2%(24/215)的患者中检出额外癌灶,其中半数(13/26)为浸润癌。
- MRI提示需处理或活检的病灶中,活检阳性预测值(PPV3)为45.6%(26/57)。
关键影像表现/征象
- MRI组66例(28.0%)共有80个MRI表现被建议进一步处理或活检。
- 21例患者的23个MRI表现术前未予处理,45例患者的57个MRI表现接受了活检。
- 26个癌灶见于24例女性,MRI检出的额外癌灶中13个(50.0%)为导管原位癌、13个(50.0%)为浸润癌。
诊断标准与关键数值
- MRI提示需处理或活检的病灶行活检的阳性预测值(PPV3)为45.6%(26/57)。
- MRI在11.2%(24/215)的患者中检出额外癌灶。
临床应用与阅片要点
- 作者认为,对于经选择的导管原位癌女性,可考虑在术前评估中使用MRI。
- 原文未据此给出具体的阅片或报告推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine if pre-operative MRI is useful for identifying additional disease that would impact surgical management in women with ductal carcinoma in situ (DCIS).
METHODS: We conducted a retrospective review of consecutive women with calcifications at mammography yielding DCIS at core biopsy from 2007 to 2016 who subsequently underwent MRI examinations. Patient characteristics, imaging findings, and pathology outcomes were collected from the medical records. Standard statistical tests were used to compare the patients who underwent MRI examinations (MRI group) and those who did not (no MRI group).
RESULTS: 963 women (age 58 years, range 28-89 years) presented with calcifications that yielded DCIS at biopsy, of whom 236 (24.5 %) underwent MRI examinations. The MRI group was younger, less likely to have a prior breast cancer, and more likely to have dense breasts than the no MRI group (all p < 0.001). 66 women (28.0 %) had 80 MRI findings that were recommended for work-up and/or biopsy. 21 patients had 23 MRI findings that were not pursued pre-operatively, and 45 patients with 57 MRI findings underwent biopsy. The positive predictive value of biopsies performed (PPV3) was 45.6 % (26/57). 26 cancers were detected in 24 women; thus, MRI detected additional sites of cancer in 11.2 % (24/215) of patients. Of the 26 cancers, 13 (50.0 %) were DCIS and 13 (50.0 %) were invasive.
CONCLUSIONS: MRI in selected women with DCIS identified additional sites of disease in 11.2 % and thus could be considered in the pre-operative evaluation of this specific patient cohort.
引用
- Lamb LR, Oseni TO, Lehman CD, et al. Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease? Eur J Radiol. 2020. PMID: 32634736. doi:10.1016/j.ejrad.2020.109130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。